- Home
- LAZR vs ASMB Comparison
LAZR vs ASMB Comparison
Compare LAZR & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAZR
- ASMB
- Stock Information
- Founded
- LAZR 2012
- ASMB 2005
- Country
- LAZR United States
- ASMB United States
- Employees
- LAZR N/A
- ASMB N/A
- Industry
- LAZR Auto Parts:O.E.M.
- ASMB Biotechnology: Pharmaceutical Preparations
- Sector
- LAZR Consumer Discretionary
- ASMB Health Care
- Exchange
- LAZR Nasdaq
- ASMB Nasdaq
- Market Cap
- LAZR 140.7M
- ASMB 141.8M
- IPO Year
- LAZR N/A
- ASMB 2010
- Fundamental
- Price
- LAZR $3.13
- ASMB $18.20
- Analyst Decision
- LAZR Hold
- ASMB Strong Buy
- Analyst Count
- LAZR 7
- ASMB 3
- Target Price
- LAZR $37.83
- ASMB $33.00
- AVG Volume (30 Days)
- LAZR 4.1M
- ASMB 28.1K
- Earning Date
- LAZR 08-12-2025
- ASMB 08-07-2025
- Dividend Yield
- LAZR N/A
- ASMB N/A
- EPS Growth
- LAZR N/A
- ASMB N/A
- EPS
- LAZR N/A
- ASMB N/A
- Revenue
- LAZR $73,313,000.00
- ASMB $32,154,000.00
- Revenue This Year
- LAZR $16.78
- ASMB $0.04
- Revenue Next Year
- LAZR $29.92
- ASMB N/A
- P/E Ratio
- LAZR N/A
- ASMB N/A
- Revenue Growth
- LAZR N/A
- ASMB 148.33
- 52 Week Low
- LAZR $2.52
- ASMB $7.75
- 52 Week High
- LAZR $26.70
- ASMB $19.93
- Technical
- Relative Strength Index (RSI)
- LAZR 48.83
- ASMB 51.38
- Support Level
- LAZR $3.05
- ASMB $17.57
- Resistance Level
- LAZR $3.56
- ASMB $18.94
- Average True Range (ATR)
- LAZR 0.32
- ASMB 0.90
- MACD
- LAZR 0.02
- ASMB -0.19
- Stochastic Oscillator
- LAZR 35.79
- ASMB 33.08
About LAZR Luminar Technologies Inc.
Luminar Technologies Inc is an automotive technology company ushering in a new era of vehicle safety and autonomy. It operates its business through the following segments: Autonomy Solutions and Advanced Technologies and Services. The majority of its revenue is generated from the Autonomy Solutions segment, which engages in the design, manufacturing, and sale of LiDAR sensors, catering mainly to the OEMs in the automobile, commercial vehicle, robo-taxi, and adjacent industries. The Advanced Technologies and Services segment provides semiconductors and related components, as well as design, test, and consulting services to the Autonomy Solutions segment and various third-party customers. Geographically, the company derives its key revenue from North America.
About ASMB Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.